Asthma
Asthma announces itself with a sound. A wheeze. A cough in the early morning. A tightness in the chest that arrives at night and feels, to a child gasping in the dark, like being smothered. The word itself comes from the Greek for panting. In 2023 it reached an estimated 363 million people across the world and caused 442,000 deaths. Most of those deaths fell in low- and lower-middle-income countries. This is a disease with no known cure, yet one that can be controlled. So why do its airways close? Why does it favor boys in childhood and women in adulthood, cities over countryside, the poor in rich nations and the affluent in poor ones? And how did a condition recognized in ancient Egypt become, for a time, a problem doctors tried to treat by analyzing the soul?
Bronchial muscles spasm. The airways inflame, grow hypersensitive, and flood with mucus. These are the mechanisms beneath every asthma symptom. The disease mainly strikes the medium-sized airways, though small and large ones can join in as it progresses. Airway inflammation is present in everyone with asthma, even when no symptoms show.
Eosinophils, neutrophils, CD4 T lymphocytes, mast cells, basophils, and macrophages all crowd into the inflamed tissue. Over time that inflammation reshapes the airway itself. The smooth muscle thickens. The tissue beneath the lining grows. More small blood vessels and nerve fibers appear, and the mucus-producing glands swell in size.
Hyperresponsiveness is the heart of the trouble. The airways contract more than normal in response to triggers, and that overreaction makes the nerves in the airways more sensitive. Contraction of smooth muscle, swelling, a thickened wall, extra mucus, and mucus plugs all narrow the passage. Airway hyperresponsiveness is excessive narrowing in response to stimuli that should be harmless, and it is somewhat reversible with treatment.
Roughly half or more of asthma susceptibility is explained by genetics, according to twin and family studies. The disease is highly polygenic, built from hundreds of common and rare variants of small effect rather than a few powerful ones. Meta-analyses now report over 200 genome-wide significant susceptibility loci, many in immune and epithelial genes.
The chromosome region 17q12-21 remains the most robustly replicated asthma locus, with its strongest effects on childhood-onset disease. Genes there, including ORMDL3 and GSDMB, appear to act through regulatory mechanisms, shaped by gene-environment interactions and early-life viral infections. Other loci cluster near IL33, TSLP, MHC class II, and GATA3, pointing toward type 2 inflammation and epithelial barrier function.
Genetic correlation analyses reveal substantial overlap between asthma and other atopic disorders such as eczema and allergic rhinitis. Polygenic risk scores drawn from multi-ancestry studies can sort individuals by risk, predicting childhood-onset disease better than adult-onset. Those in the highest percentiles show several-fold increased odds of childhood asthma, though clinical use of these scores remains investigational.
Weight gain in the mother, a stressful pregnancy, smoking while pregnant, and caesarean section have all been linked to a child developing asthma. The reach extends back a generation. Children whose maternal grandmother smoked during pregnancy are more likely to develop asthma, regardless of whether their mothers smoked or had the disease. Nicotine is believed to drive these effects through changes in DNA.
Urban environments carry higher rates than rural ones. Traffic pollution, secondhand smoke, social inequality, lack of green spaces, and industrialization concentrate in cities. Outdoor air pollution includes nitrogen dioxide, while indoor pollution ranges from asbestos and formaldehyde to mold, dust mites, cockroaches, and endotoxins. Rural settings, by contrast, offer cleaner air and early protective exposure to allergens and bacteria.
The hygiene hypothesis turns intuition on its head. Severe and recurring respiratory infections in early childhood can lower lung function and lead to asthma. Yet certain childhood infections may lessen the risk of developing it. More than 400 occupational exposures have been linked to asthma, and unlike childhood asthma, which is more common in males, adult asthma is more prevalent in females.
Peak expiratory flow tells the story of an exacerbation. An attack brings rising shortness of breath, wheezing, coughing, and chest tightness alongside falling lung function. The body recruits accessory muscles, the sternocleidomastoid and scalene, to drag in air. The chest retracts with each breath, the skin and nails turn blue, and the heart races.
A mild exacerbation drops peak expiratory flow by at least 20% over two days while daily activities grow difficult. In severe attacks, the person becomes restless and may struggle to speak as oxygen saturation falls and flow drops by more than half. Life-threatening exacerbations bring lethargy and a clouding of consciousness.
Brittle asthma describes a pattern of recurrent, severe attacks. The term survives mainly in older medical literature. It is now best regarded as a historical descriptor rather than a distinct diagnosis, no longer routine in contemporary clinical practice.
Spirometry is the most accurate measurement of lung function. It tests how much air a person can forcefully exhale in one second, the FEV1, then compares that to the total exhaled after a deep breath. The test runs twice, once without medication and once after, and a rise in FEV1 after treatment points to asthma. No single test can confirm the diagnosis on its own.
Global Initiative for Asthma guidelines ask doctors to confirm variable expiratory airflow in those with suggestive symptoms. When spirometry is unavailable, peak expiratory flow can be measured twice a day for two weeks, and daily changes greater than 10% may suggest asthma. Bronchial provocation testing uses inhaled methacholine, histamine, mannitol, or exercise to try to trigger airway narrowing, though a positive result alone does not confirm the disease.
NICE guidelines for adults start with fractional exhaled nitric oxide and blood eosinophils. Children younger than five present a special case. Rather than testing them, guidelines recommend treating those with suggestive symptoms, and GINA sets three criteria all of which must be met, including confirmed wheezing in at least one episode.
Inhaled corticosteroids form the foundation. Asthma medications fall into three categories: controllers taken daily, relievers taken as needed for severe symptoms, and additional drugs for harder cases. Doses are kept as low as possible while still preventing exacerbations. It usually takes one or two weeks for symptoms to improve after starting inhaled corticosteroids.
History reversed the order of treatment. Asthma was once managed with short-acting beta2 agonists as needed, with corticosteroids added only when symptoms persisted. Research showed that approach failed to prevent exacerbations, so guidelines now prefer inhaled corticosteroids over short-acting agonists. For teenagers and adults, the recommended first step is a combined inhaled corticosteroid and long-acting beta2 agonist inhaler.
Salbutamol, also called albuterol, treats exacerbations in repeated doses every couple of hours until symptoms ease. When attacks are severe, oral corticosteroids continue for a week afterward, with oxygen therapy to hold saturation steady. For sensitized patients, allergen-specific immunotherapy slowly introduces the allergen by injection or under the tongue, while oral corticosteroids and bronchial thermoplasty wait as last resorts for severe asthma.
In ancient Egypt, asthma was treated by drinking an incense mixture known as kyphi. Hippocrates named it a specific respiratory problem around 450 BC, borrowing the Greek word for panting. By 200 BC it was thought to be at least partly tied to the emotions. In the 12th century the physician and philosopher Maimonides wrote his Treatise on Asthma in Arabic, describing the symptoms and stressing clean air and climate.
Young Theodore Roosevelt, born in 1858, became one of the best-documented 19th-century cases. His youth was shaped by poor health and recurring nighttime attacks that felt as if he were being smothered to death, terrifying both the boy and his parents. At the time there was no effective treatment. One 1872 paper concluded asthma could be cured by rubbing the chest with chloroform liniment, and an 1880 treatment used intravenous pilocarpine.
For a stretch of the 20th century, doctors looked inward. From the 1930s to the 1950s, asthma was counted among the holy seven psychosomatic illnesses, its cause considered psychological and its treatment often psychoanalysis. Analysts heard the asthmatic wheeze as a child's suppressed cry for its mother. The pharmacological story moved the other way. Epinephrine was first cited as a treatment in 1905, isoprenaline became the first pure beta-agonist synthesized in the 1940s, and the classification of beta1 and beta2 adrenergic receptors in 1967 opened the door to the selective beta2 agonists still in use.
Continue Browsing
Common questions
What is asthma and what are its main symptoms?
Asthma is a common long-term inflammatory disease of the airways marked by variable, recurring symptoms and reduced lung function. Its symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath, often worse at night, in the early morning, or with exercise.
How many people does asthma affect and how deadly is it?
In 2023, asthma affected an estimated 363 million people worldwide and caused 442,000 deaths. Most asthma-related deaths occur in low- and lower-middle-income countries, which make up more than 80% of the mortality.
What causes asthma?
Asthma is caused by a combination of genetic and environmental factors, appearing when genetically susceptible people are exposed to specific environmental triggers. Roughly half or more of asthma susceptibility is explained by genetics, and the chromosome region 17q12-21 remains the most robustly replicated asthma locus.
How is asthma diagnosed?
Asthma cannot be diagnosed from a single test and is identified through a combination of symptoms and respiratory function testing. Spirometry is the most accurate measurement of lung function, and other tests include peak flow variability and bronchial provocation testing with substances such as methacholine, histamine, or mannitol.
How is asthma treated and can it be cured?
There is no known cure for asthma, but it can be controlled. Treatment relies on inhaled corticosteroids as controllers, relievers such as salbutamol for exacerbations, and additional medications including long-acting beta agonists, with oral corticosteroids and bronchial thermoplasty as last resorts for severe cases.
How was asthma understood and treated throughout history?
Asthma was recognized in ancient Egypt and treated with an incense mixture called kyphi, and Hippocrates named it a specific respiratory problem around 450 BC. From the 1930s to the 1950s it was considered one of the holy seven psychosomatic illnesses and often treated with psychoanalysis, while epinephrine was first cited as a treatment in 1905.
All sources
77 references cited across the entry
- 1journalAsthmaPorsbjerg C, Melén E, Lehtimäki L, Shaw D — March 2023
- 2webAsthma: diagnosis, monitoring and chronic asthma managementBritish Thoracic Society et al. — NICE — November 2024
- 4journalAsthma and comorbidities: recent advancesCazzola M, Rogliani P, Ora J, Calzetta L, Matera MG — April 2022
- 5journalStrength of association between comorbidities and asthma: a meta-analysisRogliani P, Laitano R, Ora J, Beasley R, Calzetta L — March 2023
- 6journalUnraveling the heterogeneity of asthma: Decoding subtypes of asthmaFuhlbrigge AL, Sharma S — July 2025
- 7journalDefining pediatric asthma: phenotypes to endotypes and beyondConrad LA, Cabana MD, Rastogi D — July 2021
- 8bookAllergy in Otolaryngology PracticeIge K, Joshi S — Springer Nature Switzerland — 2025
- 9bookAllergy in Otolaryngology PracticeKhurana S, Abbas F — Springer Nature Switzerland — 2025
- 10journalBrittle Asthma: Still on Board?Visca D, Ardesi F, Centis R, Pignatti P, Spanevello A — November 2023
- 11bookRespiratory medicine: lecture notesBurns GP, Bourke SJ, Macfarlane JG — Wiley Blackwell — 2022
- 12bookAirway DiseasesHavlucu Y, Kızılırmak D, Yorgancıoğlu A, Bousquet J — Springer International Publishing — 2023
- 13journalGenetic and environmental risk factors for asthma: towards preventionKoppelman GH, Pino-Yanes M, Melén E, Powell P, Bracke KR, Celedón JC, Brusselle GG — November 2025
- 14journalAsthma: epidemiology, risk factors, and opportunities for prevention and treatmentJayasooriya SM, Devereux G, Soriano JB, Singh N, Masekela R, Mortimer K, Burney P — August 2025
- 15journalThe Precision Allergy Molecular Diagnosis (PAMD@) in Monitoring the Atopic March in a Child with a Primary Food Allergy: Case ReportIzabela Knyziak-Mędrzycka et al. — 2022-09-07
- 16journalGenome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthmaHan Y, Jia Q, Jahani PS, Hurrell BP, Pan C, Huang P, Gukasyan J, Woodward NC, Eskin E, Gilliland FD, Akbari O, Hartiala JA, Allayee H — April 2020
- 17journalUnraveling the genetic architecture of asthmaHernandez-Pacheco N, Melén E — December 2022
- 18journalAsthma and the Missing Heritability Problem: Necessity for Multiomics Approaches in Determining Accurate Risk ProfilesAugustine T, Al-Aghbar MA, Al-Kowari M, Espino-Guarch M, van Panhuys N — 2022
- 19journalEpigenetics and Asthma: A Systematic ReviewAslam MD, Ageed A — October 2024
- 20journalDecoding the genetic and epigenetic basis of asthmaStikker BS, Hendriks RW, Stadhouders R — April 2023
- 21journalGenetics of preschool wheeze and its progression to childhood asthmaWolters AA, Kersten ET, Koppelman GH — January 2024
- 22journalAsthma-Genomic Advances Toward Risk PredictionHerrera-Luis E, Martin-Almeida M, Pino-Yanes M — September 2024
- 23journalPrioritization of candidate causal genes for asthma in susceptibility loci derived from UK BiobankValette K, Li Z, Bon-Baret V, Chignon A, Bérubé JC, Eslami A, Lamothe J, Gaudreault N, Joubert P, Obeidat M, van den Berge M, Timens W, Sin DD, Nickle DC, Hao K, Labbé C, Godbout K, Côté A, Laviolette M, Boulet LP, Mathieu P, Thériault S, Bossé Y — June 2021
- 24journalUpdate on the genetics of allergic diseasesLawson LP, Parameswaran S, Panganiban RA, Constantine GM, Weirauch MT, Kottyan LC — June 2025
- 25journalA polygenic risk score for asthma in a large racially diverse populationSordillo JE, Lutz SM, Jorgenson E, Iribarren C, McGeachie M, Dahlin A, Tantisira K, Kelly R, Lasky-Su J, Sakornsakolpat P, Moll M, Cho MH, Wu AC — November 2021
- 26journalPolygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary diseaseMoll M, Sordillo JE, Ghosh AJ, Hayden LP, McDermott G, McGeachie MJ, Dahlin A, Tiwari A, Manmadkar MG, Abston ED, Pavuluri C, Saferali A, Begum S, Ziniti JP, Gulsvik A, Bakke PS, Aschard H, Iribarren C, Hersh CP, Sparks JA, Hobbs BD, Lasky-Su JA, Silverman EK, Weiss ST, Wu AC, Cho MH — December 2023
- 27journalMultiancestral polygenic risk score for pediatric asthmaNamjou B, Lape M, Malolepsza E, DeVore SB, Weirauch MT, Dikilitas O, Jarvik GP, Kiryluk K, Kullo IJ, Liu C, Luo Y, Satterfield BA, Smoller JW, Walunas TL, Connolly J, Sleiman P, Mersha TB, Mentch FD, Hakonarson H, Prows CA, Biagini JM, Khurana Hershey GK, Martin LJ, Kottyan L — November 2022
- 28bookAllergy in Otolaryngology PracticeKamil RJ, Sidhaye VK, Ramanathan M — Springer Nature Switzerland — 2025
- 29journalDiagnosis and management of asthma in childrenJoanne Martin et al. — 2022
- 30journalEuropean Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 yearsErol A. Gaillard et al. — 2021
- 31journalCanadian Thoracic Society 2021 Guideline update: Diagnosis and management of asthma in preschoolers, children and adultsYang CL, Hicks EA, Mitchell P, Reisman J, Podgers D, Hayward KM, Waite M, Ramsey CD — 2021-11-02
- 32journalAsthmaO'Keefe A, Connors L, Ling L, Kim H — February 2025
- 33journalDigital interventions to improve adherence to maintenance medication in asthmaChan A, De Simoni A, Wileman V, Holliday L, Newby CJ, Chisari C, Ali S, Zhu N, Padakanti P, Pinprachanan V, Ting V, Griffiths CJ — June 2022
- 34journalThe Global Asthma Report 202225 November 2022
- 35bookThe global burden of disease: 2004 updateWorld Health Organization — 2008
- 36bookAsthmaElward G, Douglas KS — Manson Pub. — 2010
- 37journalThe pathophysiology of asthmaMaddox L, Schwartz DA — 2002
- 38journalDoes the asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) exist? A narrative review from epidemiology and practiceHahn DL — 2022
- 39journalPharmacotherapy and airway remodelling in asthma?Beckett PA, Howarth PH — February 2003
- 40journalQuality of life in pediatric asthma patients and their parents: a meta-analysis on 20 years of researchSilva N, Carona C, Crespo C, Canavarro MC — June 2015
- 41webAsthma28 April 2026
- 42reportThe Global Asthma Report 2022Global Asthma Network — 2022
- 43journalSocial inequalities in childhood asthmaPinot de Moira A, Custovic A — December 2024
- 44webWHO: AsthmaWorld Health Organization
- 45journalGlobal, regional and national burden of asthma from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021Zhang L, Jiang H, Yang G, Zhang J, Yuan S, Chen J, Tang M, Lin J, Yuan J, Yin Y — July 2025
- 46journalCharacterization of Severe Asthma WorldwideEileen Wang et al. — 2020
- 47bookSacred luxuries: fragrance, aromatherapy, and cosmetics in ancient EgyptManniche L — Cornell University Press — 1999
- 48bookMurray and Nadel's textbook of respiratory medicineMurray JF — Elsevier — 2010
- 49bookAsthma, Health and Society: A Public Health PerspectiveMalo JL, Lemière C, Gautrin D, Labrecque M, Lavoie K — Springer — 2010
- 50bookThe Cambridge History of Judaism: Volume 5: Jews in the Medieval Islamic WorldFerrario G, Kozodoy M — Cambridge University Press — 2021
- 51journalThe Life of Moses Maimonides, a Prominent Medieval PhysicianRosner F — Einstein: Albert Einstein College of Medicine — 2002
- 52bookMornings on Horseback: The Story of an Extraordinary Family, a Vanished Way of Life and the Unique Child Who Became Theodore RooseveltMcCullough D — Simon and Schuster — 1981
- 53journalOn Bronchial AsthmaThorowgood JC — November 1873
- 54journalOn the Treatment of AsthmaGaskoin G — March 1872
- 55journalThe Treatment of AsthmaBerkart JB — June 1880
- 56journalHay Fever, Asthma, and Allied AffectionsBosworth FH — 1886
- 57journalGuiding Inspiratory Flow: Development of the In-Check DIAL G16, a Tool for Improving Inhaler TechniqueSanders MJ — 2017
- 58journalAsthma History, Current Situation, an Overview of Its Control History, Challenges, and Ongoing Management Programs: An Updated ReviewKapri A, Pant S, Gupta N, Paliwal S, Nain S — November 2022
- 59journalEpinephrin; Especially in AsthmaDoig RL — February 1905
- 60journalEpinephrine: a short historyArthur G — May 2015
- 61webUse of "Race Neutral" Equations in Occupational SpirometryCowl CT — March 7, 2024
- 62journalExploring the 175-year history of spirometry and the vital lessons it can teach us todayKouri A, Dandurand RJ, Usmani OS, Chow CW — December 2021
- 63journalAsthma and depression: a pragmatic review of the literature and recommendations for future researchOpolski M, Wilson I — September 2005
- 64journalPast, present and future—b2-adrenoceptor agonists in asthma management
- 65journalSerial courses of corticotrophin or cortisone in chronic bronchial asthmaMcCombs RP — July 1952
- 66journalAppropriate use of oral corticosteroids for severe asthmaRamsahai JM, Wark PA — July 2018
- 67journalA patient with asthma seeks medical advice in 1828, 1928, and 2012von Mutius E, Drazen JM — March 2012
- 68journalA brief history of inhaled asthma therapy over the last fifty yearsCrompton G — December 2006
- 69journalDifferentiation of receptor systems activated by sympathomimetic aminesLands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG — May 1967
- 70journalAlveolar epithelial beta2-adrenergic receptorsMutlu GM, Factor P — February 2008
- 71journalPast, Present and Future Therapeutics of Asthma: A ReviewTanaka A — 2015
- 72journalCurrent issues with beta2-adrenoceptor agonists: historical backgroundTattersfield AE — 2006
- 73journalInternational trends in asthma mortality: 1970 to 1985Jackson R, Sears MR, Beaglehole R, Rea HH — November 1988
- 74journalPopulation Disparities in AsthmaGold DR, Wright R — April 2005
- 75journalAn Overview of Health Disparities in AsthmaPerez MF, Coutinho MT — September 2021
- 76bookHealth Disparities in Allergic Diseases: An Evidence-Based Look at Causes, Conditions, and OutcomesMahdavinia M — Springer Cham — 2020
- 77journalTrends in Pediatric and Adult Hospital Stays for Asthma, 2000–2010Barrett ML, Wier LM, Washington R — Agency for Healthcare Research and Quality — January 2014